CadilaLtd. is one of the largest privately held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world.
Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life.
The relationship between immunity and nutrition is well known and its role in coronavirus disease 2019 (COVID-19) is also being paid great attention. A proper diet and good nutritional status are considered important elements for an optimal immune response to prevent infections. Vitamin D supports the production of antimicrobial peptides in the respiratory epithelium, reducing the likelihood of viral infections and decreasing the severity of symptoms. Dysregulation of the renin–angiotensin system is one of the primary mechanisms of lung injury in COVID-19. Furthermore, Vitamin D upregulates anti-inflammatory mediators, which is vital when considering the hyper-inflammatory immune response caused by COVID-19. These mechanisms suggest that Vitamin D-deficient patients may be more susceptible to become infected with COVID-19 and be more likely to develop severe symptoms.
Along with Vitamin D, Vitamins C, A, E and other micronutrients such as zinc, selenium and magnesium are also important to maintain immune system. Intake of these key vitamins and minerals in people both at risk of, and suffering from COVID-19 might potentially decrease the morbidity and mortality rates.
The Most Awarded Vitamin D
“Excellence in Enhanced User Experience”
Packaging Awards 2018